Abstract
CK2 is one of the serine threonine kinases known to be essential for basic cell viability and survival. Until recently, genetic, biochemical, and cell biological studies have indicated the involvement of this enzyme in the control of cell proliferation and in signal transduction. It has been reported that more than 300 proteins have been identified as CK2 substrates in cells; however, the clarification of the functional relationship between those substrates and CK2 in the aspect of cell proliferation and survival is still required. The identification of the cellular factors involved in CK2 function is important to delineate its molecular mechanism in the cells. We previously demonstrated a significant increase in CK2 activity by growth factor stimulation of quiescent cells and identified eIF5 in the CK2 complex as being a downstream molecule. Also, we described the cell cycle-dependent association of CK2 with an endogenous tumor suppressor adenomatous polyposis coli (APC) protein, which was further investigated to uncover the negative regulation of CK2 activity by the APC-C terminal domain that is lost in more than 60 % of FAP-derived cancer cells. These results established the importance of kinase activity that seems to be non-constitutively active and controlled by unknown cellular mechanisms for properly regulating cell proliferation. We therefore examined the CK2 protein complex in the nucleus in distinct phases of cell proliferation by employing synchronized cells. Cell lysates were made after the stimulation with FBS, and nuclear fractions were extracted and immunoprecipitated with anti-CK2 polyclonal antibodies. Using two-dimensional gel electrophoresis followed by mass spectrometry analysis, we identified 22 proteins, including hnRNP, histone-binding proteins, and lamin-B, which were localized in the nuclear fraction preferentially associated with CK2 in the early G1 phase. In further studies, using nuclear CK2 immunoprecipitates followed by nanoLC mass spectrometry analysis, we identified 140 proteins as CK2-interacting proteins in the nucleus. Intriguingly, more than 20 % of these proteins were constituted by DNA-binding and RNA-binding proteins, suggesting the involvement of CK2 function as a dynamic regulator for gene function associated with cell cycle progression. Our approach can be extended to other cell states and cellular compartments and provide the broad biochemical framework for understanding the role of the kinase.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- 2D:
-
Two dimensional
- Ala:
-
Alanine
- APC:
-
Adenomatous polyposis coli
- CK2:
-
Casein kinase 2/II
- DMEM:
-
Dulbecco’s Modified Eagle’s Medium
- eIF5:
-
Eukaryotic translation initiation factor 5
- FBS:
-
Fetal bovine serum
- FDR:
-
False discovery rate
- Glu:
-
Glutamic acid
- nanoLC:
-
Nanoscale liquid chromatography
- SDS-PAGE:
-
Sodium dodecyl sulfate polyacrylamide gel electrophoresis
References
Burnett G, Kennedy E (1954) The enzymatic phosphorylation of proteins. J Biol Chem 211:969–980
Hanna DE, Rethinaswamy A, Glover CV (1995) Casein Kinase II is required for cell cycle progression during G1 and G2/M in S Cerevisiae. J Biol Chem 270:25905–25914
Filhol O, Martiel J-L, Cochet C (2004) Protein kinase CK2: a new view of an old molecular complex. EMBO Rep 5:351–355
Meggio F, Pinna LA (2003) One-thousand-and-one substrates of protein kinase CK2. FASEB J 17:349–368
Lou DY, Dominquez I, Toselli P, Landesman-Bollaq E, O’Brien C, Seldin DC (2008) The alpha catalytic subunit of protein kinase CK2 is required for mouse embryonic development. Mol Cell Biol 28:131–139
Xu X, Toselli PA, Russell LD, Seldin DC (1999) Globozoospermia in mice lacking the casein kinase II alpha' catalytic subunit. Nat Genet 23:118–121
Buchou T, Vernet M, Blond O, Jensen HH, Pointu H, Olsen BB, Cochet C, Issinger OG, Boldyreff B (2003) Disruption of the regulatory beta subunit of protein kinase CK2 in mice leads to a cell-autonomous defect and early embryonic lethality. Mol Cell Biol 23:908–915
Ahmed K, Gerber DA, Cochet C (2002) Joining the cell survival squad: an emerging role for protein kinase CK2. Trends Cell Biol 12:226–230
Litchfield DW (2003) Protein kinase CK2: Structure, regulation and role in cellular decision of life and death. Biochem J 369:1–15
Haitao J, Wang J, Nika H et al (2009) EGF-induced ERK activation promotes CK2 mediated disassociation of a-catenin from b-catenin and transactivation of b-catenin. Mol Cell 36:547–559
Duncan JS, Litchfield DW (2008) Too much of good things:the role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2. Biochim Biophys Acta 1784:33–47
Trembely JH, Wang G, Unger G, Slaton J, Ahmed K (2009) Protein kinase CK2 in health and disease: CK2 a player in cancer biology. Cell Mol Life Sci 66:1858–1867
Litchfield DW, Dobrowolska G, Krebs EG (1994) Regulation of casein kinase II by growth factors: a reevaluation. Cell Mol Biol Res 4:373–381
Sommercorn J, Mulligan JA, Lozeman FJ, Krebs EG (1987) Activation of casein kinase II in response to insulin and to epidermal growth factor. Proc Natl Acad Sci U S A 84:8834–8838
Ahn NG, Weiel JE, Chan CP, Krebs EG (1990) Identification of multiple epidermal growth factor-stimulated protein serine/threonine kinases from Swiss 3T3 cells. J Biol Chem 265:11487–11494
Niefind K, Issinger O-G (2010) Conformational plasticity of the catalytic subunit of protein kinase CK2 and its consequences for regulation and drug design. Biochim Biophys Acta 1804:484–492
Schnitzler A, Olsen BB, Issinger O-G, Niefind K (2014) The protein kinase CK2 Andante holoenzyme structure supports.J. Mol Biol 426:1871–1882
Homma MK, Wada I, Suzuki T, Yamaki J, Krebs EG, Homma Y (2005) CK2 phosphorylation of eukaryotic translation initiation factor 5 potentiates cell cycle progression. Proc Natl Acad Sci U S A 102:15688–15693
Homma MK, Li D, Krebs EG, Homma Y (2002) Association and regulation of casein kinase 2 activity by adenomatous polyposis coli protein. Proc Natl Acad Sci U S A 99:5959–5964
Homma MK, Homma Y (2005) Regulatory role of CK2 during the progression of cell cycle. Mol Cell Biochem 274:47–52
Montenarh M, Gots C (2013) The interactome of protein kinase CK2. In: Pinna EA (ed) CK2 Protein kinase. Wiley, New York, pp 76–116
Dignam JD (1990) Preparation of extracts from higher eukaryotes. In: Deutscher MP (ed) Methods in Enzymology, vol 182, Guide to Protein Purification. Academic, San Diego, pp 203–224
Ozlu N, Montigatti F, Renard BY, Field CM et al (2010) Binding partner switching on microtubules and Aurora-B in the mitosis to cytokinesis transition. Mol Cell Proteomics 9:336–350
Lessard J, Wu JI, Ranish JA et al (2007) An essential switch in subunit composition of a chromatin remodeling complex during neural development. Neuron 55:201–205
Old WM, Shabb JB, Houel S et al (2009) Functional proteomics identifies targets of phosphorylation by B-Raf signaling in melanoma. Mol Cell 34:115–131
Eric SW, Old WM, Resing KA, Ahn NG (2007) Mapping protein post-translational modifications with mass spectrometry. Nat Methods 3:798–806
Oyama M, Kozuka-Hata H et al (2009) Temporal perturbation of tyrosine phosphoproteome dynamics reveals the system-wide regulatory networks. Mol Cell Proteomics 8:226–231
Homma MK, Oyama M, Kozuka-Hata H, Ogura M and Homma. Y. Nuclear localization and phosphorylation status of protein kinase CK2 during cell cycle progression: switching in the CK2 complex, Manuscript in preparation for publication.
Phanstiel DH, Brumbaugh J, Wenger CD et al (2011) Proteomic and phosphoproteomic comparison of human ES and iPS cells. Nat Methods 8:821–827
Bian Y, Ye M, Wang C et al (2013) Global screening of CK2 kinase substrates by an integrated phosphoproteomics workflow. Sci Rep 3:3460. doi:10.1038/srep0346
Lehnert S, Gotz C, Kartarius S, Schafer B, Montenarh M (2008) Protein kinase CK2 interacts with the splicing factor hPrp3P. Oncogene 27:2390–2400
Yata K, Lloyd J et al (2012) Plk1 and CK2 act in concert to regulate Rad51 during DNA double strand break repair. Mol Cell 45:371–383
Khan D, He S, Yu J, Winter S, Cao W et al (2013) Protein kinase CK2 regulates the dimerization of histone deactylase 1(HDAC1) and HDAC2 during mitosis. J Biol Chem 288:16518–16528
Montaqnoli A, Valsasina B, Brotherton D, Troiani S (2006) Identification of Mcm2 phosphorylation sites by S-phase-regulating kinases. J Biol Chem 281:10281–10290
Panova TB, Panov KI, Russell J, Zomerdijk JCBM (2006) Casein kinase 2 associates with initiation-competent RNA polymerase I and has multiple roles in ribosomal DNA transcription. Mol Cell Biol 26:5957–5968
Homma MK, Homma Y (2008) Cell cycle and activation of CK2. Mol Cell Biochem 316:49–55
Tarrant MK, Rho H-S, Xie Z et al (2012) Regulation of CK2 by phosphorylation and O-GlcNAcylation revealed by semisynthesis. Nat Chem Biol 8:262–269
Homma MK, Oyama M, Kozuka-Hata H, Yamaki J, Koshiba S, Homma Y. Essential role for autophosphorylation of CK2α in the N-terminal region at tyrosine residues. Manuscript in preparation for publication
Acknowledgments
The authors acknowledge Drs. Dongxia Li and Tamiko Sueoka for discussions on the manuscript, Ms Junko Yamaki for her technical assistance, and Pete McCann, Roy Cameron, and Naoko Shiota for their critical reading on the manuscript. This work was supported by grants #23570170 from the Ministry of Education, Science, Sports, and Culture of Japan, Research Seeds Quest Program from the Japan Science and Technology Agency, and the Grant for Joint Research Project of the Institute of Medical Science, the University of Tokyo.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Homma, M.K. et al. (2015). Role for Protein Kinase CK2 on Cell Proliferation: Assessing CK2 Complex Components in the Nucleus During the Cell Cycle Progression. In: Ahmed, K., Issinger, OG., Szyszka, R. (eds) Protein Kinase CK2 Cellular Function in Normal and Disease States. Advances in Biochemistry in Health and Disease, vol 12. Springer, Cham. https://doi.org/10.1007/978-3-319-14544-0_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-14544-0_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-14543-3
Online ISBN: 978-3-319-14544-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)